Anthocyanins are naturally occurring flavonoids, which are responsible for the red, blue and purple colours of numerous fruits and vegetables. Present data demonstrate that anthocyanins play a role in chemoprevention. Anthocyanins carry different glucosides such as glucose, galactose, arabinose and others. Deglycosylated anthocyanins are called anthocyanidins. Depending on their skeleton, there are also different types of anthocyanidin, that is, delphinidin, petunidin and cyanidin. The phenolic structure of anthocyanins is responsible for their antioxidative activity, mainly due to their ability to scavenge reactive oxygen species [8] . Anthocyanins are also involved in the cell cycle, mainly regulatory proteins such as p53, which can additionally explain the anti-proliferative effect. In vitro studies confirm inhibitory effects on proliferation, angiogenesis and induction of apoptosis in several carcinoma cell lines (HT-29, CaCo-2 and HCT 116) [9] [10] [11] [12] . Furthermore, anthocyanins exhibited anti-inflammatory activity due to the inhibition of pro-inflammatory proteins such as nuclear factor-κB (NF-κB) and COX-2 in multiple cell types in vitro [13] .
In vivo studies using the APC (min) mouse model and the administration of azoxymethan (AOM)-induced model of colon cancer in F344 rats demonstrated reduced development of adenomas and cancer when anthocyanins were applied [14] [15] [16] .
This study was aimed at establishing murine endoscopy in an AOM-and dextran sodium sulfate (DSS)-induced model of colorectal cancer and in evaluating the effect of anthocyanins on tumour development.
Methods

Animal Studies
Female Balb/c mice weighing 20-22 g (Charles River, Germany) were used for the experiments and housed under conventional animal facility conditions. Animals obtained food and water ad libitum. The animal studies were approved by the local Institutional Review Board.
Mice were fed with normal food supplemented with 1 or 10% anthocyanin-extract, respectively (Symrise, Germany). Control group received normal food.
Two weeks before the induction of experimental colitis, this diet was started and given for the complete duration of the experiment.
Carcinogenesis was induced by one-time injection of 10 μg AOM per g mouse i.p.. After 7 days, acute colitis was induced by giving 3 and 5% DSS in drinking water (MP Biomedicals, Illkirch, France) for 7 days. For induction of chronic colitis, mice received 2 cycles of 3 or 5% DSS for 7 days interrupted by a period of 7 days with normal drinking water.
We evaluated mice data (colonic length), macroscopic and microscopic findings (tumour size, number and localisation of tumours).
Colonoscopy
Colonoscopy was performed at weeks 4 and 9 after the initiation of the experiment. Mice were anaesthetised using intraperitoneal injection of xylazin hydrochloride (Bayer, Germany).
For endoscopic evaluation, the "Coloview-system" (Karl Storz, Tuttlingen, Germany) was used [17] . It consisted of a miniature endoscope (1.9 mm outer diameter), a triple chip camera and xenon light. Inflation of the mouse colon was achieved with warm water. Biopsies were taken for histological analysis using a flexible biopsy forceps with a diameter of 3 Fr.
After the second endoscopy, mice were sacrificed as described previously [18] . Colon lengths were evaluated as a sign of inflammation. The overall number of tumours were counted and scored as follows: 0 = no sign of tumour, 1 = small, but detectable tumour, 2 = tumour growth in up to half of the colon circumference, 3 = tumours larger than half of the colon circumference.
Assessment of Histology
Besides taking biopsies in living mice, the distal third of the colon was removed after termination and used for histological analysis as described before [19] . Cross-sections of the colon were fixed in 10% buffered formalin and stained with haematoxylin-eosin. Dysplastic proliferation of glandular epithelium on microscopic cross-sections of the colon was diagnosed and graded by an experienced pathologist (P.R.) as low-grade or high-grade dysplasia (LG-IEN/HG-IEN).
Statistics
Colon lengths are given as mean and range. Statistical analyses were performed using the Student t test and Mann-Whitney rank sum test. Statistically significant differences were accepted when p < 0.05.
Results
Histology Reveals Colorectal Tumour Development in AOM DSS Mouse Model
Sections of the colon were analysed histologically. Histology confirmed the development of intraepithelial neoplasia with low-grade or high-grade dysplasia (LG-IEN/ HG-IEN) in mice treated with AOM/DSS as flat lesions or as dysplasia-associated lesion or mass as observed in human ( Fig. 1 a, b) . Dysplasia-associated invasive carcinoma was not observed.
Anthocyanin-Treated Mice Develop Less Colonic Inflammation
The reduction of colon length caused by inflammation is a known feature of DSS colitis [20] . Mice receiving 10% anthocyanins showed significantly ( p < 0.004) less reduced colon length (12. 
Anthocyanin-Treated Mice Have Macroscopically Less Tumours in the Colon
The number and size of tumours were evaluated macroscopically by colonoscopy at weeks 4 and 9 by 2 independent investigators. A total of 50 mice were included. One mouse from the 10% anthocyanin treatment group died during endoscopy. Control mice had no normal mucosa that were detectable during endoscopy, while in 1% treated mice, tumours were macroscopically less in number and size. The 10% treated mice had macroscopically almost no tumours that were detectable. Figure 3 shows a representative endoscopic picture of a tumour covering up to a half of the colonic circumference with biopsy forceps.
Becker et al. [17] developed endoscopic tumour scoring based on the number and size of tumours. In our study, we could reconfirm this scoring system during endoscopic examination, but we evaluated the number and size of tumours in detail at the end of the experiment ( Fig. 4 a-c) . Figure 5 shows median numbers of tumours depending on the tumour size for each group. Mice fed with 10% anthocyanin-rich extract revealed significantly less mean tumour numbers ( n = 1.2) compared to control ( n = 14) and anthocyanin 1% treated mice ( n = 10.6, p < 0.001).
Discussion
We studied the effect of dietary anthocyanins in an inflammation driven colorectal cancer mouse model. During the study period of 10 weeks, anthocyanin supplementation of the diet was followed by a smaller tumour size in 1% and dramatically less and smaller tumours in 10% anthocyanin-treated mice compared to the control group. In addition, the anthocyanin diet prevented inflammation-induced reduction of colon length in 10% anthocyanin-treated mice compared to control mice. So far, the exact mechanisms of how anthocyanins can inhibit colorectal cancer development are not completely clear.
In our model of cancer, histology reveals the development of intraepithelial neoplasia in all macroscopically documented tumours. No carcinoma could be found. Therefore, one could speculate that the follow up time was probably too short.
In vitro, anthocyanin extracts have an inhibitory effect on cancer cell proliferation via p21 and Bax [21] . Anthocyanins were also able to inhibit cell growth and are an inducer of cell apoptosis in colon cancer cells by modulating DNA damage [22] [23] [24] , inducing a cell cycle arrest [12, 25] or are responsible for demethylation of tumour suppressor genes [26] .
The findings on the prevention of colonic inflammation induced by DSS are in line with earlier experiments of our lab where we could demonstrate that anthocyanins have anti-inflammatory properties and ameliorate DSSinduced chronic colitis [27] . In human monocytic THP-1 cells, bilberry extract reduced interferon-γ (IFN-γ)-induced signal protein activation, pro-inflammatory gene expression and cytokine secretion, and enhanced tumor necrosis factor-α (TNF-α)-induced responses [28] . Even a recent study on biopsy samples of patients with ulcerative colitis treated with an oral anthocyanin-rich bilberry preparation during an open label clinical trial revealed reduced amounts of the proinflammatory cytokines IFN-γ and TNF-α [29] .
Anthocyanins have been reported to reduce both inflammation and tumour development via downregulation of proinflammatory enzymes and suppression of NF-κB or VCAM-1 on both mRNA and protein level [30] . In vivo, anthocyanins were also found to be protective by inducing a cell cycle arrest and having an anti-proliferative effect [25] similar to the so-far known in vitro findings.
A human pilot study of oral anthocyanins as chemoprevention in colorectal cancer used mirtocyan, a mixture of anthocyanins from bilberry extract. Thomasset et al. [31] showed a reduction in proliferation index by 7% and anthocyanin appearing in plasma, colorectal tissue and urine. Furthermore, anthocyanidins may possibly play a role as sensitizing agents in colorectal cancer therapy [32] . Cvorovic et al. [32] tested cytotoxicity of anthocyanidins in primary (Caco-2) and metastatic (LoVo and LoVo/ADR) colorectal cancer cell lines. They could demonstrate that anthocyanidins had a strong cytotoxic effect in the metastatic drug-resistant cell line (LoVo/ADR).
In conclusion, we could demonstrate a protective role of anthocyanins in the development of CRC. We showed that anthocyanins reduced colon cancer development in our model, indicating that both mechanisms (inflammation and cell growth) are simultaneously influenced by anthocyanins. Murine high resolution endoscopy enables monitoring colorectal carcinogenesis and the effects of anthocyanins on tumour development over a continuous period. Furthermore, colonic biopsies were suited for histological analysis.
However, further studies are warranted to clarify the exact mechanisms of how anthocyanins can contribute to the prevention of colon cancer in this new model of high resolution endoscopic system. In the future, biopsy samples could also be used for immunological and molecular analysis.
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